Search Within

Chau Dang

Formats
  1. Journal Article (132)
  2. Meeting Abstract (121)
  3. Guidelines (8)
  4. Book Section (4)
  5. Review (3)
  6. Book Whole (1)
  7. Editorial (1)
  8. Miscellaneous (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (272)
  2. Department of Medicine (272)
  3. Solid Tumor Oncology Division (272)
  4. Survivorship Research (272)
  5. Population Sciences Research Program (119)
  6. Epidemiology and Biostatistics (92)

More Groups

People
  1. Clifford Hudis (111)
  2. Larry Norton (76)
  3. Richard Steingart (49)
  4. Anthony Yu (46)
  5. Shanu Modi (42)
  6. Sujata Patil (41)

More People

Years
  1. 2025 (3)
  2. 2024 (12)
  3. 2023 (15)
  4. 2022 (18)
  5. 2021 (12)
  6. 2020 (20)

More Years

Publications
  1. Journal of Clinical Oncology (67)
  2. Cancer Research (42)
  3. Breast Cancer Research and Treatment (23)
  4. Annals of Oncology (10)
  5. Clinical Breast Cancer (7)
  6. Clinical Cancer Research (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (69)
  2. American Association for Cancer Research (50)
  3. Springer (33)
  4. Oxford University Press (22)
  5. Elsevier Inc. (16)
  6. American Medical Association (11)

More Publishers

Results (272)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Epoetin alfa: To give or not to give
    Journal Article

    Dang, C.; Hudis, C.; Norton, L.
    JNCI: Journal of the National Cancer Institute (2013)

    Fulltext@MSK | Save
  • Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer
    Journal Article

    Morris, P. G.; Zhou, X. K.; Milne, G. L.; Goldstein, D.; Hawks, L. C.; Dang, C. T.; Modi, S.; Fornier, M. N.; Hudis, C. A.; Dannenberg, A. J.
    Cancer Prevention Research (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Theodoulou, M.; Goldfarb, S. B.; Lake, D.; Fornier, M. N.; Modi, S.; Sklarin, N. T.; Comen, E. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Does unblinding of treatment assignment impact participant perceptions in clinical trials?
    Meeting Abstract

    Partridge, A. H.; Sepucha, K.; O'Neill, A. M.; Miller, K.; Motley, C.; Swaby, R. F.; Schneider, B. P.; Dang, C. T.; Northfelt, D. W.; Sledge, G. W.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A translational study to investigate the association between smoking-induced lung inflammation and lung metastases (LM) from breast cancer (BC)
    Meeting Abstract

    Morris, P. G.; Zhou, X. K.; Milne, G. L.; Goldstein, D. A.; Hawks, L.; Uzunaslan, D.; Dang, C. T.; Keenan, K.; Modi, S.; Fornier, M. N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Cardiac safety in a phase II study of trastuzumab emtansine (T-DM1) following anthracycline-based chemotherapy as adjuvant or neoadjuvant therapy for early-stage HER2-positive breast cancer
    Meeting Abstract

    Dang, C. T.; Gianni, L.; Romieu, G.; Dirix, L.; Campone, M.; Citron, M. L.; Zamagni, C.; Krop, I. E.; Xu, N.; Smitt, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Bevacizumab (B) in the adjuvant treatment of breast cancer - First toxicity results from Eastern Cooperative Oncology Group trial E5103
    Meeting Abstract

    Miller, K. D.; O'Neill, A.; Dang, C.; Northfelt, D.; Gradishar, W.; Sledge, G. W.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with metastatic HER2-overexpressing metastatic breast cancer
    Meeting Abstract

    Datko, F.; D'Andrea, G.; Dickler, M.; Theodoulou, M.; Goldfarb, S.; Lake, D.; Fornier, M.; Modi, S.; Sklarin, N.; Comen, E.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Phase II trial of dasatinib in combination with weekly paclitaxel for patients with metastatic breast carcinoma
    Meeting Abstract

    Morris, P. G.; Lake, D.; McArthur, H. L.; Gilewski, T.; Dang, C.; Chaim, J.; Patl, S.; Lim, K.; Norton, L.; Hudis, C. A.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Risk of rash with the anti-HER2 dimerization antibody pertuzumab: A meta-analysis
    Journal Article

    Drucker, A. M.; Wu, S.; Dang, C. T.; Lacouture, M. E.
    Breast Cancer Research and Treatment (2012)

    Fulltext@MSK | Save